CD4+ regulatory T cells in gastric cancer mucosa are proliferating and express high levels of IL-10 but little TGF-β

Gastric Cancer

Volumn 20, Issue 1, 2017, Pages 116-125

  Kindlund, Bert ^a   Sjöling, Åsa ^a   Yakkala, Chakradhar ^a   Adamsson, Jenni ^a   Janzon, Anders ^a   Hansson, Lars Erik ^b   Hermansson, Michael ^b   Janson, Peter ^c   Winqvist, Ola ^c   Lundin, Samuel B ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Gastric cancer; Helicobacter pylori; IL 10; Proliferation; Regulatory T cell

Indexed keywords

CD27 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; IL10 PROTEIN, HUMAN; MESSENGER RNA; TUMOR MARKER;

ADULT; AGED; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL POPULATION; CELL PROLIFERATION; CELL SELECTION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; CYTOKINE PRODUCTION; DEMETHYLATION; DNA METHYLATION; FEMALE; FLOW CYTOMETRY; FOXP3 GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IFN GAMMA GENE; IL 10 GENE; MALE; MIDDLE AGED; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH ADENOCARCINOMA; STOMACH CANCER; STOMACH MUCOSA; VERY ELDERLY; APOPTOSIS; BLOOD; CANCER STAGING; FOLLOW UP; GENETICS; IMMUNOLOGY; METABOLISM; PATHOLOGY; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; STOMACH TUMOR; TUMOR CELL CULTURE;

AGED; AGED, 80 AND OVER; APOPTOSIS; BIOMARKERS, TUMOR; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; DNA METHYLATION; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; FORKHEAD TRANSCRIPTION FACTORS; GASTRIC MUCOSA; HUMANS; INTERLEUKIN-10; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STOMACH NEOPLASMS; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 84954523060     PISSN: 14363291     EISSN: 14363305     Source Type: Journal    
DOI: 10.1007/s10120-015-0591-z     Document Type: Article

References (54)

1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108
2. Brenner H, Rothenbacher D, Arndt V. Epidemiology of stomach cancer. Methods Mol Biol. 2009;472:467–77.
3. Atherton JC. The pathogenesis of Helicobacter pylori-induced gastro-duodenal diseases. Annu Rev Pathol. 2006;1:63–96.
4. Mueller D, Tegtmeyer N, Brandt S, Yamaoka Y, Poire ED, Sgouras D, et al. c-Src and c-Abl kinases control hierarchic phosphorylation and function of the CagA effector protein in Western and East Asian Helicobacter pylori strains. J Clin Invest. 2012;122:1553–66.
5. Tsugawa H, Suzuki H, Saya H, Hatakeyama M, Hirayama T, Hirata K, et al. Reactive oxygen species-induced autophagic degradation of Helicobacter pylori CagA is specifically suppressed in cancer stem-like cells. Cell Host Microbe. 2012;12:764–77.
6. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57–70.
7. Conroy H, Marshall NA, Mills KHG. TLR ligand suppression or enhancement of Treg cells? A double-edged sword in immunity to tumours. Oncogene. 2008;27:168–80.
8. + regulatory T cells gradually accumulate in gliomas during tumor growth and efficiently suppress antiglioma immune responses in vivo. Int J Cancer. 2007;121:95–105.
9. Saeger H-D, Klöppel G, Kabelitz D, Kalthoff H, Hinz S, Pagerols-Raluy L, et al. Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer. Cancer Res. 2007;67:8344–50.
10. Burow M, Zhu Y, Wei S, Kryczek I, Daniel B, Gordon A, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med. 2004;10:942–9.
11. Woo EY, Chu CS, Goletz TJ, Schlienger K, Yeh H, Coukos G, et al. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer. Cancer Res. 2001;61:4766–72.
12. high regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers. Cancer Immunol Immunother. 2006;55:1064–71.
13. Yoshii M, Tanaka H, Ohira M, Muguruma K, Iwauchi T, Lee T, et al. Expression of Forkhead box P3 in tumour cells causes immunoregulatory function of signet ring cell carcinoma of the stomach. Br J Cancer. 2012;106:1668–74.
14. Zhou S, Xu S, Tao H, Zhen Z, Chen G, Zhang Z, et al. CCR7 Expression and Intratumoral FOXP3+ Regulatory T-cells are correlated with overall survival and lymph node metastasis in gastric cancer. PLoS One [Internet]. 2013 [cited 2015 Feb 5];8. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3764061/.
15. Fujii S, Sakaguchi S, Yagi H, Nomura T, Nakamura K, Yamazaki S, et al. Crucial role of FOXP3 in the development and function of human CD25+ CD4+ regulatory T-cells. Int Immunol. 2004;16:1643–56.
16. Hori S, Nomura T, Sakaguchi S. Control of regulatory T-cell development by the transcription factor Foxp3. Science. 2003;299:1057–61.
17. Rudensky AY, Gavin MA, Torgerson TR, Houston E, DeRoos P, Ho WY, et al. Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T-cell development. Proc Natl Acad Sci USA. 2006;103:6659–64.
18. − T cells. J. Clin. Invest. 2003;112:1437–43.
19. Pillai V, Ortega SB, Wang CK, Karandikar NJ. Transient regulatory T-cells: a state attained by all activated human T-cells. Clin Immunol. 2007;123:18–29.
20. high regulatory T-cells in Helicobacter pylori-infected patients. Infect Immun. 2005;73:523–31.
21. high regulatory T-cells reduce T-cell transendothelial migration in cancer patients. Eur J Immunol. 2007;37:282–91.
22. Enarsson K, Lundgren A, Kindlund B, Hermansson M, Roncador G, Banham AH, et al. Function and recruitment of mucosal regulatory T-cells in human chronic Helicobacter pylori infection and gastric adenocarcinoma. Clin Immunol. 2006;121:358–68.
23. + regulatory T-cells in gastric cancer. Int J Cancer. 2008;122:2286–93.
24. Cao M, Cabrera R, Xu Y, Firpi R, Zhu H, Liu C, et al. Hepatocellular carcinoma cell supernatants increase expansion and function of CD4(+)CD25(+) regulatory T-cells. Lab Invest. 2007;87:582–90.
25. Forman D. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Helicobacter and Cancer Collaborative Group. Gut 2001;49:347–353
26. Janzon A, Sjöling A, Lothigius A, Ahmed D, Qadri F, Svennerholm A-M. Failure to detect Helicobacter pylori DNA in drinking and environmental water in Dhaka, Bangladesh, using highly sensitive real-time PCR assays. Appl Environ Microbiol. 2009;75:3039–44.
27. Mattsson A, Tinnert A, Hamlet A, Lönroth H, Bölin I, Svennerholm AM. Specific antibodies in sera and gastric aspirates of symptomatic and asymptomatic Helicobacter pylori-infected subjects. Clin Diagn Lab Immunol. 1998;5:288–93.
28. high regulatory T-cells suppress memory T-cell responses to H. pylori in infected individuals. Infect Immun. 2003;71:1755–62.
29. + FOXP3 T-cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype. Blood. 2007;110:2983–90.
30. Kindlund B, Sjöling A, Hansson M, Edebo A, Hansson L-E, Sjövall H, et al. FOXP3-expressing CD4(+) T-cell numbers increase in areas of duodenal gastric metaplasia and are associated to CD4(+) T-cell aggregates in the duodenum of Helicobacter pylori-infected duodenal ulcer patients. Helicobacter. 2009;14:192–201.
31. Bustin SA. Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems. J Mol Endocrinol. 2002;29:23–39.
32. Bindea G, Mlecnik B, Tosolini M, Kirilovsky A, Waldner M, Obenauf AC, et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity. 2013;39:782–95.
33. Janson PCJ, Winerdal ME, Marits P, Thörn M, Ohlsson R, Winqvist O. FOXP3 promoter demethylation reveals the committed Treg population in humans. PLoS One. 2008;3:e1612.
34. + T-cells. Eur J Immunol. 2007;37:129–38.
35. Schmitt E, Klein-Hessling S, Serfling E, Hamann A, Huehn J, Floess S, et al. Epigenetic control of the foxp3 locus in regulatory T-cells. PLoS Biol. 2007;5:e38.
36. Ichihara F, Kono K, Takahashi A, Kawaida H, Sugai H, Fujii H. Increased populations of regulatory T-cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers. Clin Cancer Res. 2003;9:4404–8.
37. Goedegebuure PS, Linehan DC, Liyanage UK, Moore TT, Joo H-G, Tanaka Y, et al. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J. Immunol. 2002;169:2756–61.
38. Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD. Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol. 2002;3:991–8.
39. Reiman JM, Kmieciak M, Manjili MH, Knutson KL. Tumor immunoediting and immunosculpting pathways to cancer progression. Semin Cancer Biol. 2007;17:275–87.
40. high regulatory cells in human peripheral blood. J Immunol. 2001;167:1245–53.
41. Yaqub S, Henjum K, Mahic M, Jahnsen FL, Aandahl EM, Bjørnbeth BA, et al. Regulatory T-cells in colorectal cancer patients suppress anti-tumor immune activity in a COX-2 dependent manner. Cancer Immunol Immunother. 2008;57:813–21.
42. + Tregs. J. Clin. Invest. 2005;115:3276–84.
43. − cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10. J Immunol. 2004;172:5213–21.
44. + regulatory T-cell activity in both humans and mice. J Immunol. 2004;172:834–42.
45. Fahlén L, Read S, Gorelik L, Hurst SD, Coffman RL, Flavell RA, et al. T-cells that cannot respond to TGF-beta escape control by CD4(+)CD25(+) regulatory T cells. J Exp Med. 2005;201:737–46.
46. Lundin BS, Enarsson K, Kindlund B, Lundgren A, Johnsson E, Quiding-Järbrink M, et al. The local and systemic T-cell response to Helicobacter pylori in gastric cancer patients is characterised by production of interleukin-10. Clin Immunol. 2007;125:205–13.
47. + T-cell infiltration and high microvessel density in patients with gastric cancer. Int J Cancer. 2006;118:1909–14.
48. Hatakeyama M, Brzozowski T. Pathogenesis of Helicobacter pylori infection. Helicobacter. 2006;11(suppl 1):14–20.
49. Ribeiro ML, Bartchewsky W, Martini MR, Masiero M, Squassoni AC, Alvarez MC, et al. Effect of Helicobacter pylori infection on IL-8, IL-1beta and COX-2 expression in patients with chronic gastritis and gastric cancer. Scand J Gastroenterol. 2009;44:153–61.
50. + T cells. J Immunol. 2005;175:1483–90.
51. + T regulatory cell activities in lung cancer. Cancer Res. 2005;65:5211–20.
52. Wolf D, Rumpold H, Koppelstätter C, Gastl GA, Steurer M, Mayer G, et al. Telomere length of in vivo expanded CD4(+)CD25 (+) regulatory T cells is preserved in cancer patients. Cancer Immunol Immunother. 2006;55:1198–208.
53. Tuovinen H, Laurinolli T-T, Rossi LH, Pekkarinen PT, Mattila I, Arstila TP. Thymic production of human FOXP3(+) regulatory T-cells is stable but does not correlate with peripheral FOXP3 expression. Immunol Lett. 2008;117:146–53.
54. Wieczorek G, Asemissen A, Model F, Turbachova I, Floess S, Liebenberg V, et al. Quantitative DNA methylation analysis of FOXP3 as a new method for counting regulatory T cells in peripheral blood and solid tissue. Cancer Res. 2009;69:599–608.